摘要
目的探究马来酸麦角新碱联合米索前列醇治疗剖宫产产后出血的临床效果及对患者临床指标、血清生化指标的影响分析。方法选取2019年1月~2020年1月所收治的120例剖宫产产后出血患者进行研究,通过采用不同的治疗方式将所有患者进行随机数表分组,分为对照组和观察组,两组各60例。对照组患者采用米索前列醇进行治疗,观察组患者采用马来酸麦角新碱联合米索前列醇进行治疗,观察两组患者的临床治疗效果、临床指标的情况以及治疗前后的血清生化指标变化情况。结果治疗后,观察组患者的整体治疗效果明显高于对照组患者,观察组患者在各项临床指标表现上优于对照组患者,在治疗后的血清生化指标对比中,观察组优于对照组,差异均有统计学意义(P<0.05)。结论马来酸麦角新碱联合米索前列醇对剖宫产产后出血的患者进行治疗,比仅采用米索前列醇治疗的治疗效果有明显提高,患者术后的出血情况更少,在住院时间以及病症时长上也相对占优,另外使用联合治疗方式的患者血清指标会优于仅采用米索前列醇的患者。
Objective To explore the clinical effect of ergoxin maleate combined with misoprostol in the treatment of postpartum hemorrhage after cesarean section,and to analyze the effect on the clinical indicators and serum biochemical indicators of the patients.Methods By choosing from January 2019 to January 2020,included 120 cases of cesarean section patients with postpartum hemorrhage for research,by adopting different ways of treatment to all of the patients with random grouping,divided into control group and observation group,two groups of 60 cases,control group patients treated with misoprostol only,the observation group were treated by new maleic acid ergot alkali combined misoprostol treatment,observed the clinical therapeutic effect of two groups of patients of clinical indicators,as well as the changes of serum biochemical indexes before and after treatment.Results After the corresponding treatment mode,the overall treatment effect of the observation group was significantly higher than that of the control group(P<0.05).The performance of the control group was significantly better than that of the control group(P<0.05).In the comparison of serum biochemical indicators before and after treatment,the observation group was significantly superior to the control group(P<0.05).Conclusion New maleic acid ergot alkali misoprostol treatment of cesarean section patients with postpartum hemorrhage,can obviously increase the adoption of the therapeutic effect of misoprostol treatment,at the same time after surgery,patients with less bleeding,on the length of hospital stay and disorder of time is relatively dominant,another way to use combination therapy of patients with serum index will be better than that of patients with misoprostol only.The overall efficacy should be widely promoted and used.
作者
曾萌
秦竞霞
王婷
ZENG Meng;QIN Jing-xia;WANG Ting(Department of Obstetrics,Foshan Women and Children Hospital,Foshan,Guangdong 528000,China)
出处
《中国处方药》
2020年第7期105-106,共2页
Journal of China Prescription Drug
关键词
马来酸麦角新碱
米索前列醇
剖宫产产后出血
临床效果
血清生化指标
Ergoxin maleate
Misoprostol
Postpartum hemorrhage after cesarean section
Clinical effect
Serum biochemical index